Skip to content
Bio Special District

Bio Cluster Projects

Supporting tenant company growth in the Incheon-Siheung Metropolitan Mega Bio Cluster designated as a National Advanced Strategic Industry in 2024.

Incheon-Siheung Mega Bio Cluster
Mega Bio Cluster

Incheon-Siheung Mega Bio Cluster

In June 2024, the Ministry of Trade, Industry and Energy designated Incheon Songdo and Gyeonggi Siheung as a National Advanced Strategic Industry Bio Special District.

By integrating Songdo's large-scale production and manufacturing capabilities with Siheung Baegot's R&D, workforce development, and clinical infrastructure, the cluster is building a complete bio value chain from research and development to production and global export.

Songdo Bio Hub

Songdo Bio Special District

Incheon's Songdo International City is a global bio production and manufacturing hub with the world's largest biopharmaceutical production capacity (1.165 million liters) for a single city.

Leading Korean bio companies including Samsung Biologics, Celltrion, Lotte Biologics, and SK Bioscience are concentrated here, along with global equipment and materials companies such as Sartorius, Merck, and Thermo Fisher establishing R&D and production facilities.

Including the Songdo 11th Block expansion area (4.3 times the size of Yeouido), the district aims to attract KRW 30.7 trillion in private investment, 700 tenant companies, and 20,000 jobs by 2035.

Songdo Bio Special District

1.165M L

Biopharma Production Capacity

World's largest (single city)

2.145M L

2032 Target Capacity

Approximately 2x expansion planned

KRW 30.7T

2035 Private Investment

Including leading company investments

130,000

Expected Job Creation

KRW 37T in production-induced effects

Siheung Baegot Bio R&D
Siheung Bio R&D

Siheung Baegot Bio Special District

In partnership with Seoul National University, Siheung is building Korea's first industry-academia-research-hospital integrated bio cluster. It organically connects the R&D-focused Baegot, startup-focused Wolgot, and the Jeongwang production district.

Chong Kun Dang is investing KRW 2.2 trillion to develop a state-of-the-art biopharmaceutical R&D complex, and the 800-bed Siheung Baegot Seoul National University Hospital has commenced construction with a target opening in 2029.

An integrated education-validation-clinical platform is being established, including the gene therapy GMP facility at SNU Siheung Campus and the KTR Biomedical Research Institute.

KRW 2.2T

Chong Kun Dang R&D Investment

Largest single bio company investment in Gyeonggi

800 Beds

SNU Hospital Scale

Integrated care-research hospital (opening 2029)

KRW 2.2T

1-Year Investment Attraction

Results as of 2025

8,700 m²

KTR Bio Research Institute

Nationally certified bio certification facility

Consulting Services

Bio Special District Consulting Services

KITIM provides comprehensive consulting services for tenant companies in bio special districts.

Government Funding Consulting for Tenants

Customized consulting to help bio special district tenant companies secure government funding programs. We support the entire process from business plan preparation to post-selection management.

R&D Project Planning & Execution Support

Systematic support for government R&D project planning, application preparation, and project management in the bio and healthcare sectors.

Technology Commercialization Consulting

Support for bio technology commercialization including business model development, market analysis, and investment attraction strategy formulation.

Regulatory & Certification Support

Support for regulatory procedures in medical devices, in-vitro diagnostics, and biopharmaceuticals, as well as quality certifications such as GMP and ISO 13485.

Bio Sectors

Consulting by Bio Sector

KITIM provides specialized consulting across all areas of the bio industry.

💊

Pharmaceuticals & Drug Development

  • New drug R&D project planning
  • Non-clinical & clinical trial strategy advisory
  • Pharmaceutical GMP compliance approval support
  • Biosimilar & biobetter commercialization
  • MFDS approval strategy
🔬

Medical Devices & IVD

  • Medical device approval (KFDA/CE/FDA) consulting
  • IVD device commercialization support
  • GMP manufacturing & quality management systems
  • Clinical trial design & execution advisory
  • Overseas regulatory certification support
🧬

Digital Health & Biomaterials

  • Digital therapeutics commercialization consulting
  • SaMD (Software as a Medical Device) approval
  • Biomaterial & biodegradable material R&D planning
  • Biochemical process technology commercialization
  • Personal health record (PHR) platform development
Regulatory & Certification

Bio Regulatory Approvals & Certifications

See the key approvals and certifications bio companies need at a glance.

GMP

Good Manufacturing Practice

MFDS compliance approval, cGMP readiness

GLP

Good Laboratory Practice

Designation as a non-clinical testing facility

GCP

Good Clinical Practice

Clinical trial plan approval and conduct

KFDA Approval

MFDS Product Approval

Product approval for drugs and medical devices

CE Marking

EU Medical Device Certification

Entering the European market under MDR/IVDR

FDA 510(k)

US Medical Device Clearance

FDA premarket notification and registration

ISO 13485

Medical Device Quality Management

Quality system for medical device design & manufacturing

ISO 15189

Medical Laboratory Accreditation

Accreditation of clinical lab quality and competence

Government R&D

Government R&D Programs for Bio

Key government R&D programs available to bio companies and the scope of KITIM's consulting.

Ministry of Science and ICT

Bio & Medical Technology Development Program

Core bio technology development, new drug & medical device R&D projects

Funding: Hundreds of millions to billions of KRW per project

MSIT · MOHW · MFDS (joint)

Korea Drug Development Fund (Pan-ministerial)

Support from drug candidate discovery through clinical trials

Funding: Up to billions of KRW per stage

Ministry of Trade, Industry and Resources

Medical Device Industry R&D

Development and commercialization of innovative medical devices

Funding: Hundreds of millions of KRW per project

Ministry of SMEs and Startups

Bio Specialized Complex R&D Support

R&D for tenant companies in the Songdo and Siheung bio specialized complexes

Funding: Up to hundreds of millions of KRW per company

Ministry of Food and Drug Safety

Advanced Biopharmaceutical Demonstration Support

GMP demonstration and approval support for cell & gene therapies

Funding: Hundreds of millions of KRW per project

Ministry of Health and Welfare

Digital Healthcare Commercialization Support

Demonstration and commercialization of digital therapeutics and AI medical devices

Funding: Hundreds of millions of KRW per project

Certified Management Consultant · Certified Technical Consultant

Plan Your Bio R&D Project with Experts

Technical feasibility review by Certified Technical Consultants plus commercialization strategy advice from Certified Management Consultants raises your selection rate.

Request Consultation

Cost & Duration

We provide customized quotes based on the size of your bio company and consulting scope.

Consulting ServiceEstimated DurationCost
Bio R&D project planning consulting1–3 monthsUpon consultation
GMP compliance approval consulting3–6 monthsUpon consultation
Medical device approval (KFDA/CE/FDA)3–12 monthsUpon consultation
Bio specialized complex move-in support1–2 monthsUpon consultation
Clinical trial strategy1–3 monthsUpon consultation
ISO 13485 certification consulting3–6 monthsUpon consultation
Bio commercialization strategy1–3 monthsUpon consultation

* Actual costs vary depending on company size, regulatory scope and the nature of the R&D project. Get a customized quote through a free consultation.

Your Bio Business Growth Partner

Start customized consulting for bio cluster tenant companies.